Submitted by reuters8361 in business
The U.S. Food and Drug Administration approved a higher dose version of Regeneron Pharmaceuticals' <a href="https://www.reuters.com/markets/companies/REGN.O" target="_blank">(REGN.O)</a> drug Eylea for treatment of a disease that is a leading cause of blindne…